Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress

Endothelin (et) was first isolated and described by yanagisawa et al. and has since been described as one of the most potent known vasoconstrictor compounds. et-1 mediates its effects via two types of receptors,et and et,which are expressed in the vascular smooth muscle cells,endothelial cells,intestines and brain. secretion of et-1 results in long-lasting vasoconstriction,increased blood pressure and,in turn,overproduction of free radicals. as dysregulation of the endothelin system is an important factor in the pathogenesis of several diseases including atherosclerosis,hypertension and endotoxic shock,the et and et receptors are attractive therapeutic targets for treatment of these disorders. the biosynthesis and release of et-1 are regulated at the transcriptional level. studies have shown that p38map kinase,nuclear factor κb (nf-κb),pkc/erk and jnk/c-jun all take part in the ros-activated production of et-1. furthermore,administration of eta significantly reduces the generation of free radicals. however,treatment with etb receptor blockers does not elicit the same effect. therefore,the effects of endothelin receptor blockers on blood pressure and the generation of free radicals remain debatable. this review summarizes recent investigations into the role of endothe-lin receptor blockers with respect to the modulation of hemodynamic parameters and the generation of free radicals. © 2010 by institute of pharmacology polish academy of sciences.